Abstract
Phosphorylation of the N-terminal domain of Jun by the Jun kinases (JNKs) modulates the transcriptional activity of AP-1, a dimeric transcription factor typically composed of c-Jun and c-Fos, the latter being essential for osteoclast differentiation. Using mice lacking JNK1 or JNK2, we demonstrate that JNK1, but not JNK2, is specifically activated by the osteoclast-differentiating factor RANKL. Activation of JNK1, but not JNK2, is required for efficient osteoclastogenesis from bone marrow monocytes (BMMs). JNK1 protects BMMs from RANKL-induced apoptosis during differentiation. In addition, BMMs from mice carrying a mutant of c-Jun phosphorylation sites (JunAA/JunAA), as well as cells lacking either c-Jun or JunD, which is another JNK substrate, revealed that c-Jun phosphorylation and c-Jun itself, but not JunD, are essential for efficient osteoclastogenesis. Moreover, JNK1-dependent c-Jun phosphorylation in response to RANKL is not involved in the anti-apoptotic function of JNK1. Thus, these data provide genetic evidence that JNK1 activation modulates osteoclastogenesis through both c-Jun-phosphorylation-dependent and -independent mechanisms.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis / drug effects
-
Apoptosis / genetics
-
Binding Sites / drug effects
-
Binding Sites / genetics
-
Bone Marrow Cells / drug effects
-
Bone Marrow Cells / enzymology*
-
Cell Differentiation / drug effects
-
Cell Differentiation / physiology*
-
Cells, Cultured
-
Glycoproteins / metabolism
-
Glycoproteins / pharmacology
-
Mice
-
Mice, Knockout
-
Mitogen-Activated Protein Kinase 8
-
Mitogen-Activated Protein Kinase 9
-
Mitogen-Activated Protein Kinases / deficiency*
-
Mitogen-Activated Protein Kinases / drug effects
-
Mitogen-Activated Protein Kinases / genetics
-
Monocytes / drug effects
-
Monocytes / enzymology*
-
Mutation / genetics
-
Myeloid Progenitor Cells / drug effects
-
Myeloid Progenitor Cells / enzymology*
-
Osteoclasts / drug effects
-
Osteoclasts / enzymology*
-
Osteoprotegerin
-
Phosphorylation / drug effects
-
Proto-Oncogene Proteins c-jun / deficiency*
-
Proto-Oncogene Proteins c-jun / genetics
-
Receptors, Cytoplasmic and Nuclear / metabolism
-
Receptors, Tumor Necrosis Factor
-
Transcription Factor AP-1 / drug effects
-
Transcription Factor AP-1 / metabolism
Substances
-
Glycoproteins
-
Osteoprotegerin
-
Proto-Oncogene Proteins c-jun
-
Receptors, Cytoplasmic and Nuclear
-
Receptors, Tumor Necrosis Factor
-
Tnfrsf11b protein, mouse
-
Transcription Factor AP-1
-
Mitogen-Activated Protein Kinase 9
-
Mitogen-Activated Protein Kinase 8
-
Mitogen-Activated Protein Kinases